Next Article in Journal
Associations between Plasma Lipid Mediators and Chronic Daily Headache Outcomes in Patients Randomized to a Low Linoleic Acid Diet with or without Added Omega-3 Fatty Acids
Next Article in Special Issue
Metabolomics Analysis as a Tool to Measure Cobalt Neurotoxicity: An In Vitro Validation
Previous Article in Journal
Sulfur-Containing Amino Acids, Hydrogen Sulfide, and Sulfur Compounds on Kidney Health and Disease
Previous Article in Special Issue
Revisiting the Flora of Saudi Arabia: Phytochemical and Biological Investigation of the Endangered Plant Species Euphorbia saudiarabica
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metabolites of Geum aleppicum and Sibbaldianthe bifurca: Diversity and α-Glucosidase Inhibitory Potential

by
Nina I. Kashchenko
1,*,
Daniil N. Olennikov
1 and
Nadezhda K. Chirikova
2
1
Laboratory of Biomedical Research, Institute of General and Experimental Biology, Siberian Division, Russian Academy of Science, 6 Sakh’yanovoy Street, 670047 Ulan-Ude, Russia
2
Department of Biochemistry and Biotechnology, North-Eastern Federal University, 58 Belinsky Street, 677027 Yakutsk, Russia
*
Author to whom correspondence should be addressed.
Metabolites 2023, 13(6), 689; https://doi.org/10.3390/metabo13060689
Submission received: 27 April 2023 / Revised: 23 May 2023 / Accepted: 24 May 2023 / Published: 25 May 2023

Abstract

:
α-Glucosidase inhibitors are essential in the treatment of diabetes mellitus. Plant-derived drugs are promising sources of new compounds with glucosidase-inhibiting ability. The Geum aleppicum Jacq. and Sibbaldianthe bifurca (L.) Kurtto & T.Erikss. herbs are used in many traditional medical systems to treat diabetes. In this study, metabolites of the G. aleppicum and S. bifurca herbs in active growth, flowering, and fruiting stages were investigated using high-performance liquid chromatography with photodiode array and electrospray ionization triple quadrupole mass spectrometric detection (HPLC-PDA-ESI-tQ-MS/MS). In total, 29 compounds in G. aleppicum and 41 components in S. bifurca were identified including carbohydrates, organic acids, benzoic and ellagic acid derivatives, ellagitannins, flavonoids, and triterpenoids. Gemin A, miquelianin, niga-ichigoside F1, and 3,4-dihydroxybenzoic acid 4-O-glucoside were the dominant compounds in the G. aleppicum herb, while guaiaverin, miquelianin, tellimagrandin II2, casuarictin, and glucose were prevailing compounds in the S. bifurca herb. On the basis of HPLC activity-based profiling of the G. aleppicum herb extract, the most pronounced inhibition of α-glucosidase was observed for gemin A and quercetin-3-O-glucuronide. The latter compound and quercetin-3-O-arabinoside demonstrated maximal inhibition of α-glucosidase in the S. bifurca herb extract. The obtained results confirm the prospects of using these plant compounds as possible sources of hypoglycemic nutraceuticals.

1. Introduction

Glycemic control is an essential therapy for patients with diabetes mellitus. Monitoring of postprandial hyperglycemia by inhibiting carbohydrate hydrolases (such as α-glucosidase) can decrease the risk of complications such as cardiovascular disease, neuropathy, nephropathy, and angiopathy [1,2]. Inhibition of α-glucosidase can slow down the digestion of complex carbohydrates and, thus, reduce the release of glucose into the blood [3]. The clinically used α-glucosidase inhibitors (acarbose, voglibose, and miglitol) have common side effects, such as diarrhea and flatulence, with corresponding liver dysfunction and abdominal pain [4,5]. Thus, the search for new possible α-glucosidase inhibitors with few side effects is an important goal.
Plant-derived drugs contain natural compounds of various structures and are promising sources of α-glucosidase inhibitors [6,7]. Previously, we screened the most common tea species of the Rosaceae family growing in Siberia. High inhibitory activity of α-glucosidase (IC50 < 50 µg/mL) was a selection criterion and was used to identify promising plant species. Herb extracts of Geum aleppicum Jacq. and Sibbaldianthe bifurca (L.) Kurtto & T.Erikss. were the most active inhibitors of α-glucosidase according to their results [8]. G. aleppicum (Colurieae tribe) and S. bifurca (Potentilleae tribe) are closely related and belong to the Rosoideae subfamily [9].
G. aleppicum is an herbaceous perennial plant up to 70 cm high with an upright, reddish stem covered with stiff hairs. Basal leaves are long-petiolate and pinnate, with 3–6 pairs of cuneate–obovate lateral leaflets; the upper ones are trifoliate with large stipules and are rarely pubescent. The flowers are numerous, bright yellow, measuring 17–22 mm in diameter, rounded, on thick pedicels, and pubescent with short hairs. The native range of this species is the temperate Northern hemisphere. It grows in forests and steppe meadows, along forest edges, and near roads and residential areas [10]. The Buryat emchi-lamas use the G. allepicum herb decoction to treat diarrhea and indigestion [11]. Additionally, traditional Yakut medicine has long employed the G. allepicum decoction as an antidiabetic remedy [12]. S. bifurca (some scholars named it Potentilla bifurca) is a low shrub with woody stems in the lower part, is up to 30 cm tall, and is covered with harsh hairs. The stem leaves have oblong stipules and 2–7 pairs of lateral oblong leaflets that are obtuse at the apex. Flowers are bright yellow and measure 8–15 mm in diameter, with few-flowered apical inflorescence. S. bifurca grows in Siberian and Mongolian steppes and is found on the sandy coasts of North China [10]. This plant species is used in the Tibetan traditional medicine to treat diabetes [13]. Additionally, the extract from the whole plant is applied as an antitumor and antiulcerogenic remedy in Chinese traditional medicine [14].
The chemical composition of G. aleppicum has been insufficiently studied. The presence of some phenolic compounds, such as tiliroside, praecoxin D, eugenol, chlorogenic, gallic, salicylic acids, ethyl gallate [15], gemin A, and pedunculagin [16], is known. Additionally, triterpenoids daucosterol, β-sitosterol, and ursolic acid were previously identified [17]. Knowledge of the chemical composition of S. bifurca is low. Flavonoids have also been discovered including quercetin-4′-O-glucoside (spiraeoside) [18], quercetin-3-O-glucopyranoside, quercetin-3-O-xyloside, quercetin-3-O-(6″-O-trans-p-coumaroyl)-glucoside, quercetin, and myricetin [19]. Thus, there is a need for in-depth study of the chemical composition of these plant species.
As part of an ongoing study on the metabolome of plant species of the Rosaceae family and their antidiabetic metabolites [8,20,21,22,23,24], we performed qualitative and quantitative chromatographic analyses of the chemical compounds for the first time in herbs of G. aleppicum and S. bifurca using high-performance liquid chromatography with photodiode array detection and electrospray ionization triple quadrupole mass spectrometric detection (HPLC-PDA-ESI-tQ-MS/MS). Additionally, herb extracts of G. aleppicum and S. bifurca were bioassayed using HPLC activity-based profiling to track metabolites with the highest α-glucosidase inhibitory potential.

2. Materials and Methods

2.1. Plant Material

Plant samples of Geum aleppicum herb were collected in the Republic of Buryatia, Kyakhtinsky District in 2022. The samples were collected in steppe meadow in eight locations, 10–12 samples from each (50°20′57.2338″ N, 106°25′37.1764″ E, 902 m a.s.l.). To identify patterns in the chemical composition, samples of G. aleppicum herb were harvested during various vegetation periods: active growth (23 May), flowering (15 July) and fruiting phases (10 September). Plant samples of Sibbaldianthe bifurca herb were collected in the Republic of Buryatia, Kyakhtinsky District in 2022. The samples were collected on the steppe area near the edge of the forest in 8 locations, with a total of 10–12 samples from each (50°21′13.0499″ N, 106°24′58.3707″ E. 880 m a.s.l.). To identify patterns in the chemical composition, samples of S. bifurca herb were harvested during various vegetation periods: active growth (16 May), flowering (8 July) and fruiting phases (12 September). The species were authenticated by Prof. Tamara A. Aseeva (IGEB SB RAS, Ulan-Ude, Russia). Experimental samples of herb were collected in the morning (between 9 and 11 h). The herb samples were sealed in plastic bags and placed in a cooler with ice for transport to the laboratory. The collected herb samples were dried in a ventilated hood at a temperature of 24 °C to a moisture content of 7–9%. The herb samples were stored at 4 °C before analysis in a Plant Repository of the Institute of General and Experimental Biology. To obtain herb samples with different growth periods, herbs from each collection date were pooled. After combining the herb samples from each collection date, three total samples of each growth period (active growth, May; flowering, July; fruiting, September) were obtained for both plants. No. GAL/Pro0522/12 (total sample, May), GAL/Pro0722/10 (total sample, July), GAL/Pro0922/12 (total sample, September) were the numbers of voucher specimens of G. aleppicum herb in the Plant Repository. No. SBI/Ros0522/10 (total sample, May), SBI/Ros0722/12 (total sample, July), SBI/Ros0922/12 (total sample, September) were the numbers of voucher specimens of S. bifurca herb in the Plant Repository. The samples were ground before analysis in an A11 basic analytical mill (IKA®-WerkeGmbh & Co. KG, Staufen, Germany). Hereinafter, herb samples were sieved up to an average particle diameter of 0.5 mm using sieving machine ERL-M1 (Zernotekhnika, Moscow, Russia).

2.2. Chemicals

The reference compounds were acquired from BenchChem (Austin, TX, USA): casuarictin (Cat. No. B1680760, ≥98%), casuariin (Cat. No. B1255675, ≥98%), casuarinin (Cat. No. B1208647, ≥98%); ChemFaces (Wuhan, China): p-hydroxybenzoic acid O-glucoside (Cat. No. CFN96590, ≥98%), niga-ichigoside F1 (Cat. No. CFN91060, ≥98%), rosamultin (Cat. No. CFN89097, ≥98%); Sigma–Aldrich (St. Louis, MO, USA): acetonitrile for HPLC (Cat. No. 34851, ≥99.9%), bovine serum albumin (Cat. No. A7030, ≥98%), citric acid (Cat. No. 251275, ≥99.5%), corosolic acid (Cat. No. PHL80065, ≥90%), 3,4-dihydroxybenzoic acid 4-O-glucoside (Cat. No. E24859, ≥97%), ellagic acid (Cat. No. PHL89653, ≥98%), gallic acid (Cat. No. 398225, ≥98%), glucose (Cat. No. G8270, ≥99.5%), α-glucosidase from Saccharomyces cerevisiae (G5003), Cat. No. kaempferol-3-O-glucoside (astragalin; Cat. No. 68437, ≥90%), kaempferol-3-O-glucuronide (Cat. No. 79273, ≥97%), lithium perchlorate (Cat. No. 205281, ≥95%), malic acid (Cat. No. PHR1273, ≥99.5%), p-nitrophenyl-α-d-glucopyranoside (Cat. No. 487506), perchloric acid (Cat. No. 244252, ≥70%), quercetin-3-O-arabinoside (Cat. No. 75759, ≥95%), quercetin-3-O-glucoside (isoquercitrin; Cat. No. 16654, ≥98%), quercetin-3-O-glucuronide (Cat. No. 90733, ≥90%), sucrose (Cat. No. S0389, ≥99.5), 3,4,5-trihydroxybenzaldehyde (Cat. No. 259594, ≥98%), tormentic acid (Cat. No. PHL85836, ≥95%), ursolic acid (Cat. No. U6753, ≥90%); Toronto Research Chemicals (North York, Toronto, ON, Canada): pedunculagin (Cat. No. P354070, ≥95%). 2-Pyrone-4,6-dicarboxylic acid, agrimoniin and potentillin were previously isolated from Comarum palustre herb [22]; tellimagrandins, rugosins were isolated earlier from Filipendula ulmaria herb [23]; gemin A was isolated from Potentilla anserina herb [24]; 1-O-p-hydroxybenzoic acid O-glucoside was isolated from Calendula officinalis leaves [25]; quercetin-3-O-(6″-O-cinnamoyl)-glucoside was previously isolated from Rhaponticum uniflorum leaves [26].

2.3. Plant Extracts Preparation

To prepare plant extracts, 10 g of dry and grounded herb of G. aleppicum and S. bifurca were extracted twice via stirring in a glass flask (200 mL) with 70% methanol (100 mL) with sonication at 40 °C using a Sapphire 2.8 bath (Sapphire Ltd., Moscow, Russia) for 30 min, ultrasound power 100 W, and frequency 35 kHz. The obtained methanolic extracts were combined, filtered through a cellulose filter and concentrated under reduced pressure until dryness. Obtained extracts were stored at 4 °C before use for HPLC analysis and α-glucosidase inhibiting activity study. The yields of total extracts of G. aleppicum were 3.3 g (May sample), 3.5 g (July sample), 3.2 g (September sample). The yields of total extracts of S. bifurca were 2.8 g (May sample), 3.2 g (July sample), 3.0 g (September sample). Before analysis, dry extract (100 mg) was dissolved in 10 mL 70% methanol using measuring flask (10 mL) and filtered through 0.22 μm syringe filters.

2.4. High-Performance Liquid Chromatography with Photodiode Array Detection and Electrospray Ionization Triple Quadrupole Mass Spectrometric Detection (HPLC-PDA-ESI-tQ-MS/MS) Metabolite Profiling

To analyze the chemical profile of G. aleppicum and S. bifurca herb extracts, the previously described method used high-performance liquid chromatography with photodiode array detection and electrospray ionization triple quadrupole mass spectrometric detection (HPLC-PDA-ESI-tQ-MS/MS) was applied [8]. Chromatographic separation of compounds was realized with liquid chromatograph LC-20 Prominence coupled with a photodiode array detector, SPD-M30A (wavelength range of 200–600 nm), and a triple-quadrupole mass spectrometer, LCMS 8050 (all Shimadzu, Columbia, MD, USA). Column GLC Mastro C18 (2.1 × 150 mm, 3 μm) was used. Column temperature was 30 °C. The following eluents were used: A (0.4% formic acid in water) and B (0.4% formic acid in acetonitrile). The injection volume was 1 μL, and elution flow rate was 80 μL/min. Gradient program: 0.0–2.0 min 5.0–7.5% B, 2.0–7.0 min 7.5–15.0% B, 7.0–11.0 min 15.0–38.0% B, 11.0–14.0 min 38.0–42.0% B, 14.0–20.0 min 42.0–80.0% B, 20.0–25.0 min 80.0–100.0% B, 25.0–35.0 min 100.0–5.0% B. The negative electrospray ionization was applied for mass spectrometric detection (–3 kV source voltage, range of m/z 100–1900, collision energy 5–40 eV). There were following temperature levels of ESI interface (300 °C), desolvation line (250 °C), and heat block (400 °C). There were following flow rates of nebulizing gas (N2, 3 L/min), heating gas (air, 10 L/min), collision-induced dissociation gas (Ar, 0.3 mL/min). The data were processed with LabSolution’s workstation software (Shimadzu) equipped with the inner LC-MS library. The identification of metabolites was realized via the analysis of their retention time, ultraviolet, and mass-spectrometric data comparing the same criteria with the reference standards and literature data.

2.5. HPLC-PDA-ESI-tQ-MS/MS Metabolite Quantification

For the quantification of 34 compounds of G. aleppicum and S. bifurca herb extracts in known HPLC-PDA-ESI-tQ-MS/MS conditions (Section 2.4), the following reference compounds were used: saccharose, glucose, malic acid, citric acid, 2-pyrone-4,6-dicarboxylic acid, gallic acid, 3,4-dihydroxybenzoic acid 4-O-glucoside, 3,4,5-trihydroxybenzaldehyde, pedunculagin, 1-O-p-hydroxybenzoic acid O-glucoside, casuariin, tellimagrandin I1, tellimagrandin I2, rugosin E1, casuarinin, rugosin E2, potentillin, casuarictin, agrimoniin, gemin A, tellimagrandin II2, quercetin-3-O-glucuronide, quercetin-3-O-glucoside, quercetin-7-O-glucoside, quercetin-3-O-arabinoside, quercetin-3-O-(6″-O-cinnamoyl)-glucoside, ellagic acid, kaempferol-3-O-glucoside, kaempferol-3-O-glucuronide, niga-ichigoside F1, rosamultin, tormentic acid, corosolic acid and ursolic acid. For the preparation of stock solutions (1000 µg/mL), 10 mg of reference compounds were separately weighted and dissolved in the methanol-DMSO mixture (1:1) in volumetric flasks (10 mL) followed by the creation of ‘concentration–peak area’ graphs (1–100 µg/mL). The values of correlation coefficient (r2), standard deviation (SYX), limit of detection (LOD), limit of quantification (LOQ), and linear range were calculated in Advanced Grapher 2.2 (Alentum Software Inc., Ramat-Gan, Israel) using calibration curve data [27] and the results of three sufficient HPLC runs (Table S1). The parameters of intra-day, inter-day precisions and recovery of spiked sample were investigated using the known method [28]. The obtained results were presented as mean values ± standard deviation (S.D.).

2.6. HPLC Activity-Based Profiling

To perform HPLC activity-based profiling, aliquots (100 µL) of G. aleppicum herb extract solution (10 mg/mL) and S. bifurca herb extract solution (10 mg/mL) were separated under analytical HPLC-PDA-ESI-tQ-MS/MS conditions as described in Section 2.4. The collection of eluates (40 µL) was performed every 30 s in 96-well plates. Then, the eluates were dried and redissolved in 10 µL of phosphate-buffered saline (PBS) followed by analysis as described previously [20]. α-Glucosidase from Saccharomyces cerevisiae was dissolved in PBS (pH 6.8), which contained bovine serum albumin (0.2%) up to 0.5 U/mL concentration, then 125 µL of PBS and 60 µL p-nitrophenyl-α-d-glucopyranoside (5 mM) were added. The incubation of the samples was realized at 37 °C for 5 min. Thereafter, 60 μL of α-glucosidase (0.4 U/mL) was added. Then, the samples were incubated at 37 °C for 15 min and 50 µL of sodium carbonate (200 mM) was added. Absorbance was determined at 400 nm. Epicatechin gallate was the reference compound. The activity of the microfractions as a percentage from the activity of the reference compound was displayed on the chromatogram as bars.

2.7. Statistical Analysis

Statistical analyses were performed using one-way analysis of variance, and the significance of the mean difference was determined using Duncan’s multiple range test. Differences at p < 0.05 were considered statistically significant. The results are presented as the mean ± S.D. The linear regression analysis and generation of calibration graphs were conducted using Advanced Grapher 2.2 (Alentum Software, Inc., Ramat-Gan, Israel).

3. Results and Discussion

3.1. Metabolites of Geum aleppicum Herb: HPLC-PDA-ESI-tQ-MS/MS Profile

The Geum genus is characterized by the presence of numerous chemical classes of compounds with definite chromatographic behavior [29]. High-performance liquid chromatography with photodiode array and electrospray ionization triple quadrupole mass spectrometric detection (HPLC-PDA-ESI-tQ-MS/MS) was applied to separate compounds from the G. aleppicum herb extract. Analysis of chromatographic mobility, UV parameters, and mass spectral data and subsequent comparison of the obtained results with reference standards and/or literature information led to the identification of 29 compounds of various chemical classes (Figure 1a,b; Table 1).

3.1.1. Carbohydrates

Two carbohydrates were discovered in G. aleppicum herb extract including saccharose (1) and glucose (2). Earlier, glucose was revealed in the herb and roots of G. urbanum and leaves of G. montanum [30]. Additionally, saccharose was detected in the herbs of G. montanum [30] and G. rivale [31] and roots of G. iranicum [32].

3.1.2. Organic Acids

The presence of malic (3) and citric (4) acids was noted for the G. aleppicum herb. Previously, malic acid was found in the aerial parts of G. reptans, G. montanum, G. bulgaricum, and G. hybrid [33]. There are no data on the detection of citric acid in other species of the genus Geum.

3.1.3. Benzoic Acid Derivatives

Three benzoic acid derivatives were determined in the G. aleppicum herb. 3,4-Dihydroxybenzoic acid 4-O-glucoside (6) and 3,4,5-trihydroxybenzaldehyde (7) were identified by comparing these with reference standards. The mass spectrometric analysis of compound 9 demonstrated the loss of a hexose fragment (162 Da) and the remaining fragment with m/z 121 corresponding to a benzoic acid moiety. The assumed structure of compound 9 was found to be a benzoic acid, O-hexoside. 3,4,5-Trihydroxybenzaldehyde was revealed earlier in G. japonicum [34], while 3,4-dihydroxybenzoic acid 4-O-glucoside was found in Geum for the first time.

3.1.4. Ellagic Acid Derivatives and Ellagitannins

Ellagic acid (19), two ellagic acid glycosides (11, 12), ellagic acid ether (27), and three ellagitannins (8, 10, 16) were detected in the G. aleppicum herb. The presence of ellagitannins in G. aleppicum confirms the regularity of their presence in the Rosaceae family as a chemotaxonomic marker [16]. Comparison with reference standards allowed the identification of ellagic acid (19) and ellagitannins of different structural types according to the classification by Okuda et al. [35] such as hexahydroxyphenoyl glucose (pedunculagin, 8), C-glycosidic (casuariin, 10), and dehydrodigalloyl (gemin A, 16). The mass spectrometric analysis of 11 and 12 showed the loss of a pentosyl moiety and a methyl fragment (14 Da), leaving the moiety with m/z 301, which is specific for ellagic acid derivatives. The provisional structures of 11 and 12 were found to be the ellagic acid methyl ether O-pentosides. Previously, ellagic acid was detected in the G. rivale aerial part [36], G. urbanum rhizome [37], and G. japonicum whole plants [38]. Earlier, gemin A was identified in G. urbanum roots [39], G. japonicum leaves [40], G. rivale leaves [41], and G. aleppicum leaves [16]. Pedunculagin was revealed in G. aleppicum leaves [16], G. urbanum roots [29], and the leaves of G. aleppicum and G. calthifolium [16]. Casuariin was identified in the whole plant of G. japonicum [42] and G. urbanum roots [39]. Thus, ellagic acid and casuariin were detected in G. aleppicum for the first time.

3.1.5. Flavonoids

Six flavonoids were determined in the G. aleppicum herb extract as flavonols in the glycoside state. Depending on the flavonol structure of aglycone, they belonged to the quercetin (13, 17, 18) or kaempferol (14, 20, 21) groups. Quercetin-3-O-glucuronide (17), quercetin-3-O-glucoside (18), kaempferol-3-O-glucuronide (20), and kaempferol-3-O-glucoside (21) were successfully identified in the G. aleppicum herb using reference standards. Compound 13 was the acidic derivative of quercetin and gave the characteristic fragments of m/z 477 (quercetin O-hexuronide) and m/z 301 (quercetin). The MS pattern of compound 14 showed the loss of the fragment m/z 176 (which is characteristic of hexuronic acid) and the presence of a moiety with m/z 285 (corresponding to kaempferol). The provisional structures of compounds 13 and 14 were quercetin-O-hexuronide-O-hexuronide and kaempferol-O-hexuronide-O-hexuronide, respectively.
Previously, the presence of quercetin-3-O-glucoside was shown in the aerial part of G. rivale [36] and G. bulgaricum [43]; quercetin-3-O-glucuronide was revealed in the aerial part of G. rivale [36] and leaves of G. calthifolium var. nipponicum [44]. Additionally, kaempferol-3-O-glucoside was detected in the aerial part of G. rivale [36], G. bulgaricum [43], the whole plant of G. japonicum [45], and the herb of G. urbanum [46], while kaempferol-3-O-glucuronide was found in the aerial part of G. rivale [36] and leaves of G. calthifolium var. nipponicum [44]. Thus, the presence of quercetin-3-O-glucuronide, quercetin-3-O-glucoside, kaempferol-3-O-glucuronide, and kaempferol-3-O-glucoside was revealed in the G. aleppicum herb for the first time.

3.1.6. Triterpenoids

Six triterpenoids were identified in the G. aleppicum herb including niga-ichigoside F1 (23) and its isomer (22), rosamultin (tormentic acid O-glucoside, 25), and tormentic (26), corosolic (28), and ursolic (29) acids. All of the revealed compounds were ursane-type triterpenoids, which are often found in species of the Geum genus [15]. Previously, only ursolic acid was found in G. aleppicum [17]. Earlier, niga-ichigoside F1 was determined in the G. japonicum plant [47], the aerial part of G. rivale [36], the roots of G. urbanum [48], and in the G. japonicum Thunb. var. chinense plant [15]. Rosamultin was found in the G. japonicum plant [49]. Tormentic acid was found in the aerial part of G. rivale [36], the G. japonicum plant [47], roots of G. urbanum [48], and the G. japonicum Thunb. var. chinense plant [15]. Corosolic acid was found in the G. japonicum plant [49]; ursolic acid was found in the aerial part of G. rivale [36], whole plant of G. japonicum [50], and G. urbanum roots [51]. Thus, niga-ichigoside F1 and rosamultin, tormentic, and corosolic acids were discovered in the G. aleppicum herb for the first time.

3.2. Metabolites of Sibbaldianthe bifurca Herb: HPLC-PDA-ESI-tQ-MS/MS Profile

HPLC–PDA–ESI–tQ–MS/MS was used to separate metabolites from the S. bifurca herb extract. Analysis of chromatographic mobility, UV parameters, and mass spectral data and subsequent comparison of the obtained results with reference standards and/or literature information led to the identification of 41 compounds of various chemical classes (Figure 2a,b; Table 2).

3.2.1. Carbohydrates and Organic Acids

The carbohydrates [saccharose (1) and glucose (2)] and two organic acids [malic (3) and citric (4)] were discovered in the S. bifurca herb upon comparison of tr, UV, and mass spectra data with reference standards. Previously, these compounds were not detected in the Sibbaldianthe genus.

3.2.2. Galloyl O-Glycosides

Gallic acid (8) in the free state and twelve of its hexosides (3, 6, 7, 11, 14, 1720, 22, 29, 34) were detected in the S. bifurca herb extract. Found hexosides were characterized by the number of galloyls: one (monogalloyl hexose, 3, 6, 7), two (digalloyl hexose, 11, 14, 17), three (trigalloyl hexose, 1820, 22), four (tetragalloyl hexose, 29), and five (pentagalloyl hexose, 34). Gallic acid was detected using the reference standard, while galloyl O-hexosides were identified in the mass spectrum with deprotonated ions [M–H] of m/z 331 (mono-), 483 (di-), 635 (tri-), 787 (tetra-), and 939 (penta-), and daughter ions related to the loss of gallic acid. Gallic acid was not previously found in the Sibbaldianthe genus.

3.2.3. Benzoic Acid Derivatives

Three benzoic acid derivatives (9, 10, and 13) were determined in the S. bifurca herb. 3,4-Dihydroxybenzoic acid 4-O-glucoside (9) and 1-O-p-hydroxybenzoic acid O-glucoside (13) were identified by comparing these with reference standards. Compound 10 was established as p-hydroxybenzoic acid O-hexoside owing to specific UV (274 nm) and mass spectral patterns with the loss of a hexose fragment (162 Da) and the presence of ions with m/z 137 corresponding to the hydroxybenzoic acid moiety. 3,4-Dihydroxybenzoic acid 4-O-glucoside and 1-O-p-hydroxybenzoic acid O-glucoside were found in the Sibbaldianthe genus for the first time.

3.2.4. Ellagic Acid Derivatives and Ellagitannins

Ellagic acid (35), ellagic acid ether (41), and thirteen ellagitannins (12, 15, 16, 21, 2328, 30, 31, 36) were revealed in the S. bifurca herb. The identification of ellagic acid (35) and ellagitannins of different structural types, such as hexahydroxyphenoyl glucose (pedunculagin, 12), C-glycosidic (casuariin, 10; casuarinin, 25; casuarictin, 28), dehydrodigalloyl (agrimoniin, 30), hexahydroxyphenoylgalloyl glucose (potentillin, 27; tellimagrandins: I1, 16; I2, 21; II2, 31), and valoneoyl (rugosin E1, 24; rugosin E2, 26), was realized via comparison with reference standards [52]. The mass spectra of 23 and 36 gave typical ions of the deprotonated molecules [M–H] (m/z 951 and 1087, respectively) and double-charged molecules [M–2H]2− (m/z 475 and 543, respectively). Provisional structures of 23 and 26 were found to be trigalloyl-hexahydroxydiphenoyl-hexoside and digalloyl-bis-hexahydroxydiphenoyl-hexoside, respectively [21,53]. The mass spectra of 41 showed the loss of a methyl fragment (14 Da) and the presence of a fragment with m/z 301, which is specific to ellagic acid. The provisional structure of 41 was found to be an ellagic acid methyl ether. Previously, ellagitannins had not been found in the genus Sibbaldianthe.

3.2.5. Flavonoids

The flavonoid profile of the S. bifurca herb was similar to that of the G. aleppicum herb, i.e., the presence of quercetin (33, 3840) and kaempferol (32, 37) derivatives was found. All six flavonoids were revealed in the glycoside state. Quercetin-3-O-glucuronide (33), kaempferol-3-O-glucuronide (37), quercetin-7-O-glucoside (38), quercetin-3-O-arabinoside (39), and quercetin-3-O-(6″-O-cinnamoyl)-glucoside were identified in the S. bifurca herb upon comparison of tr, UV, and mass spectral data to reference standards. Compound 32 gave the deprotonated ion [M–H] with m/z 609 and the aglycone fragment in the MS2 spectra at m/z 285, which is characteristic for kaempferol. Additionally, the loss of a hexosyl moiety was observed. The tentative structure of 32 was kaempferol-O-hexoside-hexoside. Quercetin-3-O-glucuronide, kaempferol-3-O-glucuronide, quercetin-7-O-glucoside, quercetin-3-O-arabinoside, and quercetin-3-O-(6″-O-cinnamoyl)-glucoside were found in the Sibbaldianthe genus for the first time.

3.3. Quantitative Content and Seasonal Variation of Profile of Geum aleppicum and Sibbaldianthe bifurca Herb

To identify possible patterns in the chemical profile of the G. aleppicum herb and S. bifurca herb, these species were collected and investigated at different growth phases: active growth (May), flowering (July), and fruiting (September). The maximum content of the majority of compounds in both species was observed during the flowering period. In particular, gemin A, miquelianin (quercetin-3-O-glucuronide), niga-ichigoside F1, 3,4-dihydroxybenzoic acid 4-O-glucoside, and glucose were the dominant compounds of the G. aleppicum herb. The contents of different ellagitannins increased towards the flowering phase and then decreased upon fruiting. Thus, the content of the dominant ellagitannin, gemin A, in the active growth phase (10.18 mg/g) increased more than five times by the flowering phase (53.26 mg/g), and then, it gradually decreased in the fruiting stage (42.11 mg/g). A similar trend was observed for both casuariin (1.26 mg/g → 2.57 mg/g → 2.03 mg/g) and pedunculagin (trace → 0.26 mg/g → trace). In contrast, the content of ellagic acid was the maximum in the fruiting phase (5.63 mg/g), which occurred possibly because ellagic acid was released during the hydrolysis of ellagitannins [54]. Flavonoids, both derivatives of quercetin and kaempferol, accumulated the most in the flowering phase of the G. aleppicum herb. The content of the prevalent quercetin derivative, miquelianin, in the active growth phase increased from 5.20 mg/g to 26.83 mg/g in the flowering period. One possible reason for the maximum accumulation of flavonoids in the G. aleppicum herb in the flowering phase may be the high UV radiation and air temperature. Previously, similar accumulations of flavonols at high growth temperatures were observed in other representatives of the Rosaceae family [21,55].
Guaiaverin (quercetin-3-O-arabinoside), miquelianin, tellimagrandin II2, casuarictin, and glucose were the dominant compounds in the S. bifurca herb. The accumulation of the dominant flavonoids, guaiaverin and miquelianin, was also observed during the growth phase (21.59 and 19.62 mg/g, respectively). The concentrations of dominant ellagitannins, tellimagrandin II2 and casuarictin, increased until the flowering stage and then consistently decreased until the fruiting period (3.62 mg/g → 7.83 mg/g → 5.16 mg/g and 1.60 mg/g → 5.28 mg/g → 4.16 mg/g, respectively). The maximum content of gallotannins was observed in samples during the growth phase, followed by a decrease in the flowering and fruiting phase samples. This can likely be explained by the fact that galloyl hexoses are precursors of complex hydrolysable tannins, the biosynthesis of which is carried out via oxidative binding of galloyl groups [56,57]. Thus, the maximum accumulation of dominant ellagitannins and flavonoids in the G. aleppicum and S. bifurca herbs under Siberian conditions was observed during the flowering phase in July.

3.4. Chemotaxonomic Significance of G. aleppicum and S. bifurca Metabolites

As a result of the chromatographic investigation of the G. allepicum and S. bifurca herbs, 70 metabolites of different chemical classes were identified. To select compounds of chemotaxonomic significance for these species, particular attention should be paid to 2-pyrone-4,6-dicarboxylic acid, hydrolysable ellagitannins, and flavonols.
Currently, S. bifurca belongs to the Potentilleae tribe [58], and G. aleppicum belongs to the Colluria tribe, although earlier, experts attributed it to the tribe Dryadeae [9]. Both species are closely related and belong to the Rosoideae subfamily [9]. 2-Pyrone-4,6-dicarboxylic acid is a breakdown product of phenolic compounds and is a taxonomic marker of the Rosoideae subfamily [59]. Both the G. aleppicum and S. bifurca herbs contained 2-pyrone-4,6-dicarboxylic acid, which confirmed the results reported by Wilkes et al. on the presence of this compound in representatives of the Rosoideae subfamily [59].
Ellagitannins have a wide distribution in the Rosaceae family [60], while oligomeric hydrolysable tannins are limited to the Rosoideae subfamily [16]. According to this theory, most species of the Rosoideae subfamily contain one or two oligomers that are used as chemotaxonomic markers. In the studied plant objects, dimer gemin A for the G. aleppicum herb and dimers rugosin E and agrimoniin for the S. bifurca herb may have chemotaxonomic significance.
Flavonoids have also been proposed as a chemotaxonomic marker of the Rosaceae family [61]. Derivatives of kaempferol and quercetin were revealed in both the G. aleppicum and S. bifurca herbs. However, these species did not contain any specific flavonoids that would allow us to discuss chemosystematic markers. Thus, the exact chemosystematic significance of flavonols in the Rosoideae subfamily is not definitively due to their wide presence in Rosaceae in general.

3.5. α-Glucosidase Inhibiting Activity of Geum aleppicum and Sibbaldianthe bifurca Herb Extract: HPLC Activity-Based Profiling

To reveal the components of G. aleppicum and S. bifurca herb extracts with α-glucosidase-inhibiting properties, the HPLC activity-based profiling method was used. This is a highly multipurpose strategy to miniaturize and accelerate identification of active substances in analyzed extracts by analytical HPLC [62,63]. HPLC activity-based profiling is performed via post-column collection of microfractions in a plate after a certain period of time, their subsequent drying, and the addition of reagents for biological evaluation [64,65]. The activity of the microfractions as a percentage of the activity of the reference compound is displayed on the chromatogram as bars (Figure 1c). Epicatechin gallate was chosen as the reference compound due to its high ability to inhibit α-glucosidase with IC50 value of 4.03 ± 0.01 μg/mL [66]. Epicatechin gallate isolated from Rhodiola crenulata roots inhibited α-glucosidase with IC50 0.71 ± 0.01 [67].
As a result of HPLC activity-based profiling of the G. aleppicum herb extract, inhibition of α-glucosidase by 3,4-dihydroxybenzoic acid 4-O-glucoside, gemin A, quercetin-3-O-glucuronide, niga-ichigoside F1, and rosamultin was found. The most pronounced inhibition of α-glucosidase was observed for ellagitannin gemin A and flavonol quercetin-3-O-glucuronide. The same procedure for the S. bifurca herb extract revealed inhibition of α-glucosidase by tetragalloyl hexose, quercetin 3-O-glucuronide, quercetin-7-O-glucoside, and quercetin-3-O-arabinoside (Figure 2c). Maximal inhibition of α-glucosidase was found for the flavonols quercetin-3-O-glucuronide and quercetin-3-O-arabinoside. Previously, it was suggested that the mechanism of the inhibitory activity of ellagitannins against α-glucosidase involves their binding to proteins, followed by changes in the conformation of the enzyme and a decrease in its activity [68,69]. In turn, flavonols bind to glucosidase with high affinity through hydrogen bonds and van der Waals forces, and then, these complexes lead to conformational changes in α-glucosidase [70,71]. Thus, microfractionation of the G. aleppicum and S. bifurca herb extracts allowed direct evaluation of the α-glucosidase inhibitory activity of the components in their biological matrices. The obtained results can serve as a basis for using these plant compounds as possible sources for hypoglycemic nutraceutical production.

4. Conclusions

The Geum aleppicum and Sibbaldianthe bifurca herbs are used in traditional medicine as antidiabetic remedies. In an attempt to identify compounds with antidiabetic potential, these closely related plant species were first characterized via HPLC-PDA-ESI-tQ-MS/MS and, as a result, data on 70 compounds were obtained. Carbohydrates, organic acids, derivatives of benzoic and ellagic acids, ellagitannins, flavonoids and triterpenoids were identified in both plant species. Then, HPLC activity-based profiling was applied, which allowed one to miniaturize and accelerate the identification of active substances in the analyzed extracts. Gemin A, quercetin-3-O-glucuronide and quercetin-3-O-arabinoside showed the most pronounced results in terms of α-glucosidase inhibition. In this study, the G. aleppicum and S. bifurca herbs were shown to be natural sources of metabolites with α-glucosidase-inhibiting properties. Further in vivo investigations of these plant extracts are necessary for the wide introduction of new biologically active agents into therapeutic practice for the treatment of diabetes mellitus.

Supplementary Materials

The following supporting information are available at: https://www.mdpi.com/article/10.3390/metabo13060689/s1, Table S1: Regression equations, correlation coefficients (r2), standard deviation (SYX), limits of detection (LOD), limits of quantification (LOQ), linear ranges, intra-day, inter-day precisions and recovery of spiked samples for 34 reference standards. Figure S1: Structures of compounds identified in Geum aleppicum and Sibbaldianthe bifurca.

Author Contributions

Conceptualization, N.I.K. and D.N.O.; methodology, D.N.O.; software, N.K.C.; validation, N.I.K., D.N.O. and N.K.C.; formal analysis, N.I.K.; investigation, D.N.O.; resources, N.K.C.; data curation, D.N.O.; writing—original draft preparation, N.I.K.; writing—review and editing, D.N.O.; visualization, N.K.C.; supervision, D.N.O.; project administration, N.I.K.; funding acquisition, N.K.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ministry of Education and Science of Russia, grant numbers 121030100227-7; FSRG-2023-0027.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Acknowledgments

The authors acknowledge the Buryat Research Resource Center for the technical support in chromatographic and mass-spectrometric research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Schmidt, J.S.; Nyberg, N.T.; Staerk, D. Assessment of constituents in Allium by multivariate data analysis, high-resolution α-glucosidase inhibition assay and HPLC-SPE-NMR. Food Chem. 2014, 161, 192–198. [Google Scholar] [CrossRef]
  2. Cardullo, N.; Muccilli, V.; Pulvirenti, L.; Cornu, A.; Pouységu, L.; Deffieux, D.; Quideau, S.; Tringali, C. C-glucosidic ellagitannins and galloylated glucoses as potential functional food ingredients with anti-diabetic properties: A study of α-glucosidase and α-amylase inhibition. Food Chem. 2020, 313, 126099. [Google Scholar] [CrossRef] [PubMed]
  3. Zhang, Z.; Luo, A.; Zhong, K.; Huang, Y.; Gao, Y.; Zhang, J.; Gao, H.; Xu, Z.; Gao, X. α-Glucosidase inhibitory activity by the flower buds of Lonicera japonica Thunb. J. Func. Foods 2013, 5, 1253–1259. [Google Scholar] [CrossRef]
  4. Feng, J.; Yang, X.-W.; Wang, R.-F. Bio-assay guided isolation and identification of α-glucosidase inhibitors from the leaves of Aquilaria sinensis. Phytochemistry 2011, 72, 242–247. [Google Scholar] [CrossRef]
  5. Sudhir, R.; Mohan, V. Postprandial hyperglycemia in patients with type 2 diabetes mellitus. Treat. Endocrinol. 2002, 1, 105–116. [Google Scholar] [CrossRef]
  6. Dirir, A.M.; Daou, M.; Yousef, A.F.; Yousef, L.F. A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochem. Rev. 2022, 21, 1049–1079. [Google Scholar] [CrossRef]
  7. Kashtoh, H.; Baek, K.-H. Recent updates on phytoconstituent alpha-glucosidase inhibitors: An approach towards the treatment of type two diabetes. Plants 2022, 11, 2722. [Google Scholar] [CrossRef] [PubMed]
  8. Kashchenko, N.I.; Olennikov, D.N. Phenolome of Asian agrimony tea (Agrimonia asiatica Juz., Rosaceae): LC-MS profile, α-glucosidase inhibitory potential and stability. Foods 2020, 9, 1348. [Google Scholar] [CrossRef] [PubMed]
  9. Potter, D.; Eriksson, T.; Evans, R.; Oh, S.; Smedmark, J.E.E.; Morgan, D.R.; Kerr, M.; Robertson, K.R.; Arsenault, M.; Dickinson, T.A.; et al. Phylogeny and classification of Rosaceae. Plant Syst. Evol. 2007, 266, 5–43. [Google Scholar] [CrossRef]
  10. Komarov, V.L. Flora of USSR; AN SSSR: Moscow, Russia, 1941; Volume X, pp. 81–254. [Google Scholar]
  11. Batorova, S.M.; Yakovlev, G.P.; Aseeva, T.A. Reference-Book of Traditional Tibetan Medicine Herbs; Nauka: Novosibirsk, Russia, 2013; pp. 67–73. [Google Scholar]
  12. Makarov, A.A. Plant Medical Remedies of Yakut Traditional Medicine; YaGU: Yakutsk, Russia, 1974; pp. 47–51. [Google Scholar]
  13. Tang, X.; Li, J.; Liu, L.; Jing, H.; Zuo, W.; Zeng, Y. Transcriptome analysis provides insights into Potentilla bifurca adaptation to high altitude. Life 2022, 12, 1337. [Google Scholar] [CrossRef]
  14. Liu, Y.; Xiang, S.; Fu, X. Characterization of the complete chloroplast genome sequence of medicinal plant: Potentilla bifurca (Rosaceae). Mitochondrial DNA B Resour. 2021, 6, 143–144. [Google Scholar] [CrossRef] [PubMed]
  15. Cheng, X.R.; Jin, H.Z.; Qin, J.J.; Fu, J.J.; Zhang, W.D. Chemical constituents of plants from the genus Geum. Chem. Biodivers. 2011, 8, 203–222. [Google Scholar] [CrossRef] [PubMed]
  16. Okuda, T.; Yoshida, T.; Hatano, T.; Iwasaki, M.; Kubo, M.; Orime, T.; Yoshizaki, M.; Naruhashi, N. Hydrolysable tannins as chemotaxonomic markers in the Rosaceae. Phytochemistry 1992, 31, 3091–3096. [Google Scholar] [CrossRef]
  17. Yang, W.; Zheng, M.S.; Lu, H.Z. 2013. Study the chemical constituents of Geum aleppicum Jacq. J. Med. Sci. Yanbian Univ. 2013, 36, 32–34. [Google Scholar]
  18. Piao, X.; Tian, Y.; Mi, X.; Cui, J. Tyrosinase inhibition of Potentilla bifurca. China J. Chin. Mater. Med. 2009, 34, 1952–1954. [Google Scholar]
  19. Wang, G.Y.; Yan, P.Y.; Liu, W.; Liu, L.K.; Li, J.P.; Zeng, Y. Potentilla bifurca flavonoids effectively improve insulin resistance. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 8358–8369. [Google Scholar] [CrossRef]
  20. Kashchenko, N.I.; Chirikova, N.K.; Olennikov, D.N. Agrimoniin, an active ellagitannin from Comarum palustre herb with anti-α-glucosidase and antidiabetic potential in streptozotocin-induced diabetic rats. Molecules 2017, 22, 73. [Google Scholar] [CrossRef]
  21. Kashchenko, N.I.; Olennikov, D.N.; Chirikova, N.K. Metabolites of Siberian raspberries: LC-MS profile, seasonal variation, antioxidant activity and, thermal stability of Rubus matsumuranus phenolome. Plants 2021, 10, 2317. [Google Scholar] [CrossRef]
  22. Olennikov, D.N. Ellagitannins and other phenolic compounds from Comarum palustre. Chem. Nat. Compd. 2016, 52, 721–723. [Google Scholar] [CrossRef]
  23. Olennikov, D.N.; Kruglova, M.Y. A new quercetin glucoside and other phenolic compounds from the genus Filipendula. Chem. Nat. Compd. 2013, 49, 610–616. [Google Scholar] [CrossRef]
  24. Olennikov, D.N.; Kashchenko, N.I.; Chirikova, N.K.; Kuz’mina, S.S. Phenolic profile of Potentilla anserina L. (Rosaceae) herb of Siberian origin and development of a rapid method for simultaneous determination of major phenolics in P. anserina pharmaceutical products by microcolumn RP-HPLC-UV. Molecules 2014, 20, 224–248. [Google Scholar] [CrossRef] [PubMed]
  25. Olennikov, D.N.; Kashchenko, N.I. Componential profile and amylase inhibiting activity of phenolic compounds from Calendula officinalis L. leaves. Sci. World J. 2014, 2014, 654193. [Google Scholar] [CrossRef] [PubMed]
  26. Olennikov, D.N.; Kashchenko, N.I. New flavonoids and turkesterone-2-O-cinnamate form leaves of Rhaponticum uniflorum. Chem. Nat. Compd 2019, 55, 256–264. [Google Scholar] [CrossRef]
  27. Olennikov, D.N.; Chirikova, N.K.; Kashchenko, N.I.; Nikolaev, V.M.; Kim, S.-W.; Vennos, C. Bioactive phenolics of the genus Artemisia (Asteraceae): HPLC-DAD-ESI-TQ-MS/MS profile of the Siberian species and their inhibitory potential against α-amylase and α-glucosidase. Front. Pharmacol. 2018, 9, 756. [Google Scholar] [CrossRef]
  28. Olennikov, D.N.; Zilfikarov, I.N.; Penzina, T.A. Use of microcolumn HPLC for analysis of aloenin in Aloe arborescens raw material and related drugs. Pharm. Chem. J. 2013, 47, 494–497. [Google Scholar] [CrossRef]
  29. Granica, S.; Kłębowska, A.; Kosiński, M.; Piwowarski, J.P.; Dudek, M.K.; Kaźmierski, S.; Kiss, A.K. Effects of Geum urbanum L. root extracts and its constituents on polymorphonuclear leucocytes functions. Significance in periodontal diseases. J. Ethnopharmacol. 2016, 188, 1–12. [Google Scholar] [CrossRef]
  30. Aubert, S.; Choler, P.; Pratt, J.; Douzet, R.; Gout, E.; Bligny, R. Methyl-β-d-glucopyranoside in higher plants: Accumulation and intracellular localization in Geum montanum L. leaves and in model systems studied by 13C nuclear magnetic resonance. J. Exp. Bot. 2004, 55, 2179–2189. [Google Scholar] [CrossRef]
  31. Ming, D.S.; Jiang, R.W.; But, P.P.; Towers, G.H.; Yu, D.Q. A new compound from Geum rivale L. J. Asian Nat. Prod. Res. 2002, 4, 217–220. [Google Scholar] [CrossRef]
  32. Shahani, S.; Gohari, A.R.; Monsef-Esfahani, H.R. Quantification of sucrose in the root of Geum iranicum Khatamsaz. Pharm. Biomed. Res. 2015, 1, 31–36. [Google Scholar] [CrossRef]
  33. Berkov, S.; Kasabova, N.; Pavlova, D.; Tonkov, S. Metabolic and chemotaxonomical studies in some Geum (Rosaceae) species. Phytol. Balc. 2017, 23, 7–16. [Google Scholar]
  34. Suh, S.J.; Cho, K.J.; Moon, T.C.; Chang, H.W.; Park, Y.G.; Kim, C.H. 3,4,5-trihydroxybenzaldehyde from Geum japonicum has dual inhibitory effect on matrix metalloproteinase 9; inhibition of gelatinoytic activity as well as MMP-9 expression in TNF-alpha induced HASMC. J. Cell Biochem. 2008, 105, 524–533. [Google Scholar] [CrossRef] [PubMed]
  35. Okuda, T.; Yoshida, T.; Hatano, T. Correlation of oxidative transformation of hydrolysable tannins and plant evolution. Phytochemistry 2000, 55, 513–529. [Google Scholar] [CrossRef] [PubMed]
  36. Panizzi, L.; Catalano, S.; Miarelli, C.; Cioni, P.L.; Campeol, E. In vitro antimicrobial activity of extracts and isolated constituents of Geum rivale. Phytother. Res. 2000, 14, 561–563. [Google Scholar] [CrossRef] [PubMed]
  37. Gstirner, F.; Widenmann, H. Contents of the rhizome of Geum urbanum. Sci. Pharm. 1964, 32, 98–104. [Google Scholar]
  38. Yang, Z.; Yue, S.-J.; Gao, H.; Zhang, Q.; Xu, D.-Q.; Zhou, J.; Li, J.-J.; Tang, Y.-P. Natural deep eutectic solvent-ultrasound assisted extraction: A green approach for ellagic acid extraction from Geum japonicum. Front. Nutr. 2023, 9, 1079767. [Google Scholar] [CrossRef]
  39. Piwowarski, J.P.; Granica, S.; Kosiński, M.; Kiss, A.K. Secondary metabolites from roots of Geum urbanum L. Biochem. System. Ecol. 2014, 53, 46–50. [Google Scholar] [CrossRef]
  40. Yoshida, T.; Okuda, T.; Memon, M.U.; Shingu, T. Structure of gemin A, a new dimeric ellagitannin having α- and β-glucose cores. J. Chem. Soc. Chem. Commun. 1982, 6, 351–353. [Google Scholar] [CrossRef]
  41. Moilanen, J.; Salminen, J.-P. Ecologically neglected tannins and their biologically relevant activity: Chemical structures of plant ellagitannins reveal their in vitro oxidative activity at high pH. Chemoecology 2008, 18, 73–83. [Google Scholar] [CrossRef]
  42. Dong, H.; Chen, S.X.; Kini, R.M.; Xu, H.X. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade. J. Nat. Prod. 1998, 61, 1356–1360. [Google Scholar] [CrossRef]
  43. Kamińska, J.; Assenow, I. Phytochemical studies of Geum bulgaricum Panc. Acta Pol. Pharm. 1971, 28, 201–206. [Google Scholar]
  44. Murai, Y.; Iwashina, T. Flavonol glucuronides from Geum calthifolium var. nipponicum and Sieversia pentapetala (Rosaceae). Biochem. System. Ecol. 2010, 38, 1081–1082. [Google Scholar] [CrossRef]
  45. Xu, H.-X.; Kadota, S.; Wang, H.; Kurokawa, M.; Shiraki, K. A new hydrolyzable tannin from Geum japonicum and its antiviral activity. Heterocycles 1994, 38, 167–175. [Google Scholar]
  46. Zaharieva, M.M.; Dimitrova, L.L.; Philipov, S.; Nikolova, I.; Vilhelmova, N.; Grozdanov, P.; Nikolova, N.; Popova, M.; Bankova, V.; Konstantinov, S.M.; et al. In vitro antineoplastic and antiviral activity and in vivo toxicity of Geum urbanum L. extracts. Molecules 2022, 27, 245. [Google Scholar] [CrossRef] [PubMed]
  47. Shigenaga, S.; Kouno, I.; Kawano, N. Triterpenoids and glycosides from Geum japonicum. Phytochemistry 1985, 24, 115–118. [Google Scholar] [CrossRef]
  48. Dimitrova, L.; Zaharieva, M.M.; Popova, M.; Kostadinova, N.; Tsvetkova, I.; Bankova, V.; Najdenski, H. Antimicrobial and antioxidant potential of different solvent extracts of the medicinal plant Geum urbanum L. Chem. Cent. J. 2017, 11, 113. [Google Scholar] [CrossRef]
  49. Yean, M.-H.; Kim, J.-S.; Hyun, Y.-J.; Hyun, J.-W.; Bae, K.-H.; Kang, S.-S. Terpenoids and phenolics from Geum japonicum. Korean J. Pharmacogn. 2012, 43, 107–121. [Google Scholar]
  50. Xu, H.X.; Zeng, F.Q.; Wan, M.; Sim, K.Y. Anti-HIV triterpene acids from Geum japonicum. J. Nat. Prod. 1996, 59, 643–645. [Google Scholar] [CrossRef]
  51. Ton That, Q.; Nguyen Thien, T.V.; Dang, H.P.; Le Hoan, N.; Vo, L.K.T.; Nguyen, M.H.D.; Ngu, N.T.; Nguyen, T.S.; Hansen, P.E. Chemical constituents of Geum urbanum L. roots. Nat. Prod. Res. 2018, 32, 2529–2534. [Google Scholar] [CrossRef]
  52. Okuda, T.; Yoshida, T.; Hatano, T. Oligomeric hydrolyzable tannins, a new class of plant polyphenols. Heterocycles 1990, 30, 1195. [Google Scholar] [CrossRef]
  53. Moilanen, J.; Sinkkonen, J.; Salminen, J.P. Characterization of bioactive plant ellagitannins by chromatographic, spectroscopic and mass spectrometric methods. Chemoecology 2013, 23, 165–179. [Google Scholar] [CrossRef]
  54. Schulenburg, K.; Feller, A.; Hoffmann, T.; Schecker, J.H.; Martens, S.; Schwab, W. Formation of β-glucogallin, the precursor of ellagic acid in strawberry and raspberry. J. Exp. Bot. 2016, 67, 2299–2308. [Google Scholar] [CrossRef] [PubMed]
  55. Wang, S.Y.; Zheng, W. Effect of plant growth temperature on antioxidant capacity in strawberry. J. Agric. Food Chem. 2001, 49, 4977–4982. [Google Scholar] [CrossRef] [PubMed]
  56. Grochowski, D.M.; Skalicka-Woźniak, K.; Orhan, I.E.; Xiao, J.; Locatelli, M.; Piwowarski, J.P.; Granica, S.; Tomczyk, M. A comprehensive review of agrimoniin. Ann. N. Y. Acad. Sci. 2017, 1401, 166–180. [Google Scholar] [CrossRef] [PubMed]
  57. Tuominen, A.; Salminen, J.-P. Hydrolyzable tannins, flavonol glycosides, and phenolic acids show seasonal and ontogenic variation in Geranium sylvaticum. J. Agric. Food Chem. 2017, 65, 6387–6403. [Google Scholar] [CrossRef]
  58. Feng, T.; Moore, M.J.; Yan, M.-H.; Sun, Y.-X.; Zhang, H.-J.; Meng, A.-P.; Li, X.-D.; Jian, S.-G.; Li, J.-Q.; Wang, H.-C. Phylogenetic study of the tribe Potentilleae (Rosaceae), with further insight into the disintegration of Sibbaldia. J. Syst. Evol. 2017, 55, 177–191. [Google Scholar] [CrossRef]
  59. Wilkes, S.; Glasl, H. Isolation, characterization, and systematic significance of 2-pyrone-4,6-dicarboxylic acid in Rosaceae. Phytochemistry 2001, 58, 441–449. [Google Scholar] [CrossRef]
  60. Okuda, T. Systematics and health effects of chemically distinct tannins in medicinal plants. Phytochemistry 2005, 66, 2012–2031. [Google Scholar] [CrossRef]
  61. Challice, J.S. Phenolic compounds of the subfamily Pomoideae: A chemotaxonomic survey. Phytochemistry 1972, 12, 1095–1101. [Google Scholar] [CrossRef]
  62. Hamburger, M. HPLC-based activity profiling for pharmacologically and toxicologically relevant natural products—Principles and recent examples. Pharm. Biol. 2019, 57, 328–334. [Google Scholar] [CrossRef]
  63. Mahmoud, A.B.; Danton, O.; Kaiser, M.; Khalid, S.; Hamburger, M.; Mäser, P. HPLC-based activity profiling for antiprotozoal compounds in Croton gratissimus and Cuscuta hyalina. Front. Pharmacol. 2020, 11, 1246. [Google Scholar] [CrossRef]
  64. Akaberi, M.; Danton, O.; Tayarani-Najaran, Z.; Asili, J.; Iranshahi, M.; Emami, S.A.; Hamburger, M. HPLC-based activity profiling for antiprotozoal compounds in the endemic Iranian medicinal plant Helichrysum oocephalum. J. Nat. Prod. 2019, 82, 958–969. [Google Scholar] [CrossRef] [PubMed]
  65. Kongstad, K.T.; Özdemir, C.; Barzak, A.; Wubshet, S.G.; Staerk, D. Combined use of high-resolution α-glucosidase inhibition profiling and high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy for investigation of antidiabetic principles in crude plant extracts. J. Agric. Food Chem. 2015, 63, 2257–2263. [Google Scholar] [CrossRef] [PubMed]
  66. Wu, X.; Hu, M.; Hu, X.; Ding, H.; Gong, D.; Zhang, G. Inhibitory mechanism of epicatechin gallate on α-amylase and α-glucosidase and its combinational effect with acarbose or epigallocatechin gallate. J. Mol. Liq. 2019, 290, 111202. [Google Scholar] [CrossRef]
  67. Yin, Z.; Zhang, W.; Feng, F.; Zhang, Y.; Kang, W. α-Glucosidase inhibitors isolated from medicinal plants. Food Sci. Hum. Wellness 2014, 3, 136–174. [Google Scholar] [CrossRef]
  68. Toda, M.; Kawabata, J.; Kasai, T. Inhibitory effects of ellagi- and gallotannins on rat intestinal α-glucosidase complexes. Biosci. Biotechnol. Biochem. 2001, 65, 542–547. [Google Scholar] [CrossRef]
  69. Spencer, C.M.; Cai, Y.; Martin, R.; Gaffney, S.H.; Goulding, P.N.; Mangnolato, D.; Lilley, Y.; Haslam, E. Polyphenol complexation—Some thoughts and observatios. Phytochemistry 1988, 27, 2397–2409. [Google Scholar] [CrossRef]
  70. Peng, X.; Zhang, G.; Liao, Y.; Gong, D. Inhibitory kinetics and mechanism of kaempferol on α-glucosidase. Food Chem. 2016, 190, 207–215. [Google Scholar] [CrossRef]
  71. Proença, C.; Freitas, M.; Ribeiro, D.; Oliveira, E.F.T.; Sousa, J.L.C.; Tomé, S.M.; Ramos, M.J.; Silva, A.M.S.; Fernandes, P.A.; Fernandes, E. α-Glucosidase inhibition by flavonoids: An in vitro and in silico structure-activity relationship study. J. Enzyme Inhib. Med. Chem. 2017, 32, 1216–1228. [Google Scholar] [CrossRef]
Figure 1. High-performance liquid chromatography with electrospray ionization triple quadrupole mass spectrometric detection (hPlC-PDA-ESI-tQ-MS/MS) base peak chromatogram (a); selected ion monitoring mode (SIM), negative ionization (b); HPLC activity-based profiling of α-glucosidase-inhibition (c) of G. aleppicum herb extract (July sample). Compounds are numbered as listed in Table 1.
Figure 1. High-performance liquid chromatography with electrospray ionization triple quadrupole mass spectrometric detection (hPlC-PDA-ESI-tQ-MS/MS) base peak chromatogram (a); selected ion monitoring mode (SIM), negative ionization (b); HPLC activity-based profiling of α-glucosidase-inhibition (c) of G. aleppicum herb extract (July sample). Compounds are numbered as listed in Table 1.
Metabolites 13 00689 g001
Figure 2. High-performance liquid chromatography with electrospray ionization triple quadrupole mass spectrometric detection (HPLC-PDA-ESI-tQ-MS/MS) base peak chromatogram (a); selected ion monitoring mode (SIM), negative ionization (b); HPLC activity-based profiling of α-glucosidase-inhibition (c) of S. bifurca herb extract (July sample). Compounds are numbered as listed in Table 2.
Figure 2. High-performance liquid chromatography with electrospray ionization triple quadrupole mass spectrometric detection (HPLC-PDA-ESI-tQ-MS/MS) base peak chromatogram (a); selected ion monitoring mode (SIM), negative ionization (b); HPLC activity-based profiling of α-glucosidase-inhibition (c) of S. bifurca herb extract (July sample). Compounds are numbered as listed in Table 2.
Metabolites 13 00689 g002
Table 1. Chromatographic (tr), UV and mass-spectrometric data, and seasonal presence/content of compounds 129 found in G. aleppicum herb extract.
Table 1. Chromatographic (tr), UV and mass-spectrometric data, and seasonal presence/content of compounds 129 found in G. aleppicum herb extract.
Notr, minCompound aUV, nm[M–H], MS/MS, m/zSeasonal Content, mg/g DW ± SD
MayJulySeptember
12.39Saccharose S205341 [M–H]2.39 ± 0.1324.18 ± 1.2341.68 ± 2.55
22.55Glucose S205179 [M–H]3.86 ± 0.2348.52 ± 2.9627.11 ± 1.63
32.78Malic acid S205133 [M–H]2.63 ± 0.145.69 ± 0.369.18 ± 0.53
43.04Citric acid S205191 [M–H]0.93 ± 0.053.11 ± 0.205.73 ± 0.36
53.662-Pyrone-4,6-dicarboxylic acid S314183 [M–H]; [183]→139 [(M–H)–CO2], 111 [(M–H)–COOH–CO]0.83 ± 0.045.29 ± 0.325.33 ± 0.32
66.323,4-Dihydroxybenzoic acid 4-O-Glc S297315 [M–H]; [315]→153 [(M–H)–Glc]2.44 ± 0.1711.27 ± 0.6210.86 ± 0.68
76.723,4,5-Trihydroxybenzaldehyde S275153 [M–H]traces0.08 ± 0.01traces
87.04Pedunculagin S270783 [M–H]; 391 [M–2H]2−traces0.26 ± 0.02traces
98.50Benzoic acid O-Hex L265283 [M–H]; [283]→121 [(M–H)–Hex]0.83 ± 0.054.33 ± 0.284.08 ± 0.22
108.59Casuariin S270783 [M–H]; 391 [M–2H]2−1.26 ± 0.082.57 ± 0.152.03 ± 0.12
1110.16Ellagic acid methyl ether O-Pent L254, 360447 [M–H]; [447]→315 [(M–H)–Pent]; [315]→301 [(M–H)–Pent–CH2]traces0.54 ± 0.030.10 ± 0.01
1210.82Ellagic acid methyl ether O-Pent L254, 360447 [M–H]; [447]→315 [(M–H)–Pent]; [315]→301 [(M–H)–Pent–CH2]traces0.32 ± 0.02traces
1310.96Quercetin-O-HexA-O-HexA L254, 267, 351653 [M–H]; [653]→477 [(M–H)–HexA], 301 [(M–H)–2×HexA]traces0.82 ± 0.05traces
1412.29Kaempferol-O-HexA-O-HexA L265, 345637 [M–H]; [637]→461 [(M–H)–HexA], 285 [(M–H)–2×HexA]0.26 ± 0.011.89 ± 0.130.29 ± 0.02
1512.73Feruloyl tartronic acid L296, 327295 [M–H]; [295]→193 [(M–H)–102]1.07 ± 0.073.97 ± 0.252.18 ± 0.13
1614.47Gemin A S2701871 [M–H]; 935 [M–2H]2−10.18 ± 0.7053.26 ± 3.2542.11 ± 2.11
1715.49Quercetin-3-O-GlcA S254, 268, 352477 [M–H]; [477]→301 [(M–H)–GlcA]5.20 ± 0.3026.83 ± 1.5810.75 ± 0.59
1815.84Quercetin-3-O-Glc S254, 285, 355463 [M–H]; [463]→301 [(M–H)–Glc]traces1.28 ± 0.07traces
1915.88Ellagic acid S255, 367301 [M–H]traces0.89 ± 0.055.63 ± 0.38
2016.55Kaempferol-3-O-GlcA S265, 344461 [M–H]; [461]→285 [(M–H)–GlcA]1.03 ± 0.062.97 ± 0.182.08 ± 0.11
2116.66Kaempferol-3-O-Glc S265, 343447 [M–H]; [447]→285 [(M–H)–Glc]traces0.52 ± 0.03traces
2216.92Niga-ichigoside F1 isomer L210665 [M–H]; [665]→503 [(M–H)–Glc]1.22 ± 0.072.01 ± 0.122.09 ± 0.13
2317.69Niga-ichigoside F1 S210665 [M–H]; [665]→503 [(M–H)–Glc]4.27 ± 0.2310.82 ± 0.668.12 ± 0.44
2418.62Gallocatechin gallate O-gallate L250593 [M–H]; [593]→441 [(M–H)–GallA]traces2.93 ± 0.171.14 ± 0.06
2519.84Rosamultin (tormentic acid O-Glc) S210649 [M–H]; [649]→487 [(M–H)–Glc]0.74 ± 0.051.73 ± 0.101.93 ± 0.11
2624.27Tormentic acid S210487 [M–H]0.52 ± 0.041.14 ± 0.071.37 ± 0.08
2725.42Ellagic acid methyl ether L254, 362315 [M–H]; [315]→301 [(M–H)–CH2]0.14 ± 0.010.63 ± 0.041.83 ± 0.11
2827.50Corosolic acid S210471 [M–H]0.10 ± 0.010.43 ± 0.020.69 ± 0.04
2931.31Ursolic acid S210455 [M–H]traces0.05 ± 0.000.67 ± 0.04
a Compound identification was based on comparison of retention time and MS spectral data with reference standard (S) or interpretation of MS spectral data and comparison with literature data (L). Traces—<LOQ (limit of quantification). Abbreviation used: Glc—glucose; Hex—hexose; Pent—pentose; HexA—hexuronic acid; GlcA—glucuronic acid.
Table 2. Chromatographic (tr), UV and mass-spectrometric data, and seasonal presence/content of compounds 141 found in S. bifurca herb extract.
Table 2. Chromatographic (tr), UV and mass-spectrometric data, and seasonal presence/content of compounds 141 found in S. bifurca herb extract.
Notr, minCompound aUV, nm[M–H], MS/MS, m/zSeasonal Content, mg/g DW ± SD
MayJulySeptember
12.39Saccharose S205341 [M–H]1.86 ± 0.10 2.14 ± 0.1226.18 ± 1.57
22.55Glucose S205179 [M–H]3.96 ± 0.226.29 ± 0.423.35 ± 0.17
32.78Malic acid S205133 [M–H]2.52 ± 0.15 4.27 ± 0.305.83 ± 0.36
43.04Citric acid S205191 [M–H]2.69 ± 0.18 4.83 ± 0.308.59 ± 0.50
53.662-Pyrone-4,6-dicarboxylic acid S314183 [M–H]; [183]→139 [(M–H)–CO2], 111 [(M–H)–COOH–CO]0.50 ± 0.031.29 ± 0.071.14 ± 0.06
63.72Monogalloyl hexose L268331 [M–H]; [331]→169 [(M–H)–Hex]2.93 ± 0.161.54 ± 0.113.22 ± 0.19
74.93Monogalloyl hexose L268331 [M–H]; [331]→169 [(M–H)–Hex]2.97 ± 0.182.83 ± 0.174.69 ± 0.28
85.42Gallic acid S272169 [M–H]0.29 ± 0.020.82 ± 0.060.80 ± 0.05
96.323,4-Dihydroxybenzoic acid 4-O-Glc S273343 [M–H]; [343]→181 [(M–H)–Glc]0.92 ± 0.061.63 ± 0.111.29 ± 0.08
106.64p-Hydroxybenzoic acid O-hexoside isomer L274299 [M–H]; [299]→137 [(M–H)–Glc]0.83 ± 0.051.52 ± 0.091.16 ± 0.06
116.85Digalloyl hexose L272483 [M–H]; [483]→331 [(M–H)–GalA]tracestracestraces
127.04Pedunculagin S270783 [M–H]; 391 [M–2H]2−tracestracestraces
138.141-O-p-Hydroxybenzoic acid O-Glc S274299 [M–H]−; [299]→137 [(M–H)–Glc]−1.16 ± 0.072.32 ± 0.152.09 ± 0.13
148.41Digalloyl hexose L272483 [M–H]−; [483]→331 [(M–H)–GalA]−0.42 ± 0.020.29 ± 0.02traces
158.59Casuariin S270783 [M–H]−; 391 [M–2H]2−tracestracestraces
169.34Tellimagrandin I1 S272785 [M–H]−; 392 [M–2H]2−; 1571 [2M–H]−traces0.53 ± 0.03traces
179.77Digalloyl hexose L272483 [M–H]−; [483]→331 [(M–H)–GalA]−0.51 ± 0.030.39 ± 0.030.10 ± 0.01
1810.26Trigalloyl hexose L274635 [M–H]−; [635]→483 [(M–H)–GalA]−0.59 ± 0.040.42 ± 0.020.24 ± 0.01
1910.51Trigalloyl hexose L274635 [M–H]−; [635]→483 [(M–H)–GalA]−0.78 ± 0.040.58 ± 0.040.43 ± 0.02
2010.95Trigalloyl hexose L274635 [M–H]−; [635]→483 [(M–H)–GalA]−2.58 ± 0.162.14 ± 0.142.03 ± 0.12
2111.28Tellimagrandin I2 S272785 [M–H]−; 392 [M–2H]2−; 1571 [2M–H]−0.52 ± 0.031.16 ± 0.071.10 ± 0.07
2212.16Trigalloyl hexose L274635 [M–H]−; [635]→483 [(M–H)–Hex]−3.56 ± 0.212.89 ± 0.202.72 ± 0.18
2312.55Trigalloyl-HHDP-Hex L273951 [M–H]; 475 [M–2H]2−0.37 ± 0.020.26 ± 0.1traces
2413.38Rugosin E1 S2721721 [M–H]; 860 [M–2H]2−traces0.50 ± 0.03traces
2513.47Casuarinin S272935 [M–H]; 467 [M–2H]2−traces0.93 ± 0.06traces
2613.82Rugosin E2 S2721721 [M–H]; 860 [M–2H]2−tracestracestraces
2714.12Potentillin S272935 [M–H]; 467 [M–2H]2−traces0.09 ± 0.01traces
2814.31Casuarictin S276937 [M–H]; 468 [M–2H]2−1.60 ± 0.095.28 ± 0.314.16 ± 0.28
2914.66Tetragalloyl hexose L271787 [M–H]; [787]→635 [(M–H)–GalA]3.14 ± 0.162.83 ± 0.150.83 ± 0.05
3014.94Agrimoniin S271935 [M–H]; 467 [M–2H]2−traces0.26 ± 0.02traces
3115.07Tellimagrandin II2 S276937 [M–H]; 468 [M–2H]2−3.62 ± 0.217.83 ± 0.515.16 ± 0.33
3215.38Kaempferol-3-O-Hex-Hex L265, 344609 [M–H]; [609]→447 [(M–H)–Glc], 285 [(M–H)–2×Glc]0.14 ± 0.010.52 ± 0.030.50 ± 0.03
3315.49Quercetin-3-O-GlcA S254, 268, 352477 [M–H]−; [477]→301 [(M–H)–GlcA]−7.88 ± 0.4919.62 ± 1.2012.84 ± 0.73
3415.67Pentagalloyl hexose L272939 [M–H]−; [939]→787 [(M–H)–GalA]−0.84 ± 0.050.52 ± 0.03traces
3515.88Ellagic acid S255, 367301 [M–H]−traces1.26 ± 0.083.18 ± 0.19
3615.93Digalloyl-bis-HHDP-Hex L2711087 [M–H]−; 543 [M–2H]2−0.17 ± 0.010.10 ± 0.01traces
3716.55Kaempferol-3-O-GlcA S265, 344461 [M–H]−; [461]→285 [(M–H)–GlcA]−traces3.22 ± 0.193.35 ± 0.20
3816.76Quercetin-7-O-Glc S254, 268, 364463 [M–H]−; [463]→301 [(M–H)–Glc]−0.26 ± 0.014.29 ± 0.264.35 ± 0.29
3917.64Quercetin-3-O-Ara S253, 268, 365433 [M–H]−; [433]→301 [(M–H)–Ara]−5.63 ± 0.3321.59 ± 1.4518.26 ± 1.06
4018.59Quercetin-3-O-(6″-O-Cin)-Glc S270, 285, 364593 [M–H]−; [593]→463 [(M–H)–Cin]−, 301 [(M–H)–Glc]−0.08 ± 0.011.53 ± 0.100.16 ± 0.01
4125.42Ellagic acid methyl ether L254, 362315 [M–H]−; [315]→301 [(M–H)–CH2]−0.18 ± 0.012.53 ± 0.153.19 ± 0.16
a Compound identification was based on comparison of retention time and MS spectral data with reference standard (S) or interpretation of MS spectral data and comparison with literature data (L). Traces—<LOQ (limit of quantification). Abbreviation used: Glc—glucose; HHDP—hexahydroxyphenoyl; Hex—hexose; GlcA—glucuronic acid; GalA—gallic acid; Ara—arabinose; Cin—cinnamoyl.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kashchenko, N.I.; Olennikov, D.N.; Chirikova, N.K. Metabolites of Geum aleppicum and Sibbaldianthe bifurca: Diversity and α-Glucosidase Inhibitory Potential. Metabolites 2023, 13, 689. https://doi.org/10.3390/metabo13060689

AMA Style

Kashchenko NI, Olennikov DN, Chirikova NK. Metabolites of Geum aleppicum and Sibbaldianthe bifurca: Diversity and α-Glucosidase Inhibitory Potential. Metabolites. 2023; 13(6):689. https://doi.org/10.3390/metabo13060689

Chicago/Turabian Style

Kashchenko, Nina I., Daniil N. Olennikov, and Nadezhda K. Chirikova. 2023. "Metabolites of Geum aleppicum and Sibbaldianthe bifurca: Diversity and α-Glucosidase Inhibitory Potential" Metabolites 13, no. 6: 689. https://doi.org/10.3390/metabo13060689

APA Style

Kashchenko, N. I., Olennikov, D. N., & Chirikova, N. K. (2023). Metabolites of Geum aleppicum and Sibbaldianthe bifurca: Diversity and α-Glucosidase Inhibitory Potential. Metabolites, 13(6), 689. https://doi.org/10.3390/metabo13060689

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop